Case Comprehensive Cancer Center

Co-leader of Case CCC's Immune Oncology Program, David Wald, MD, PhD, has already improved the landscape of CAR T immunotherapy by developing an ultra-fast procedure that cuts CAR T cell manufacturing from two weeks to less than 24 hours. However, harvesting T cells to make CAR T therapy…

A study, recently published in Proceedings of the National Academy of Sciences (PNAS) and co-led by Sanford Markowitz, MD, PhD, CWRU Distinguished University Professor and Case CCC Cancer Genomics and Epigenomics Program member, discovered that SW033291—a drug that was originally developed in the…

Sydney Evans, a member of the Community Outreach and Engagement team at the Case Comprehensive Cancer Center and community navigator for the Cleveland African American Prostate Cancer Project, was named a 40 Under 40 Emerging Legend by the Black Professionals Association Charitable…

An article highlighting Case CCC's Youth Enjoy Science (YES) program, Saying YES to Careers in Cancer Research: A Collaborative Model for Evaluating and Improving a Cancer Education and Research Program, was recently published in the European Society of Medicine with J.T. Render as first author.…

Sichun Yang, PhD, a member of Case CCC's Molecular Oncology Program, and Alberto Montero, MD, a Developmental Therapeutics Program member, are looking for patient advocates for a follow-up study to Yang's recent structure-function study, The sequence-structure-function relationship of intrinsic ERα…

Be sure to offer a friendly Case CCC greeting when you see any of the 40 exceptional undergraduates from across the country as they arrive on May 27 as part of the prestigious Cancer-focused Summer Undergraduate Research (CanSUR) Program. This year’s cohort was selected from an impressive 664…

Case Comprehensive Cancer Center Population and Cancer Prevention Program member, Peter Hovmand, PhD, MSW, has been named Director of the Center for Community Health Integration, Division of General Medical Sciences, at Case Western Reserve University's School of Medicine. The Pamela B. Davis…

Reshmi Parameswaran was recently appointed director of the Cancer Biology Training Program (CBTP). The goal of the CBTP is to train PhD and MD/PhD scientists who will advance research on the causes, diagnosis, progression and treatment of experimental and human cancer. The CBTP provides a PhD…

Over 100 individuals from healthcare institutions, community organizations, and a local high school joined members and staff of Case CCC for the 8th Cancer Disparities Symposium on March 6-7 to learn about and discuss the successes and future directions of clinical trials across the…

A special class of ribonucleic acid (RNA) molecules, called long intergenic non-coding RNAs (lincRNA), may provide a new target for preventing and treating gastric, or stomach, cancer, according to Case CCC Cancer Genomics and Epigenomics Program member Kishore Guda, DVM, PhD, who led the team that…